497 related articles for article (PubMed ID: 28786275)
1. [THE ROLE OF SEMAPHORIN 7A IN SYSTEMIC SCLEROSIS].
Rimar D; Slobodin G; Rosner I; Rozenbaum M; Kaly L; Boulman N; Jiries N; Awisat A; Vadasz Z
Harefuah; 2017 Jul; 156(7):418-421. PubMed ID: 28786275
[TBL] [Abstract][Full Text] [Related]
2. Role of semaphorin 7a signaling in transforming growth factor β1-induced lung fibrosis and scleroderma-related interstitial lung disease.
Gan Y; Reilkoff R; Peng X; Russell T; Chen Q; Mathai SK; Homer R; Gulati M; Siner J; Elias J; Bucala R; Herzog E
Arthritis Rheum; 2011 Aug; 63(8):2484-94. PubMed ID: 21484765
[TBL] [Abstract][Full Text] [Related]
3. Endogenous Semaphorin-7A Impedes Human Lung Fibroblast Differentiation.
Esnault S; Torr EE; Bernau K; Johansson MW; Kelly EA; Sandbo N; Jarjour NN
PLoS One; 2017; 12(1):e0170207. PubMed ID: 28095470
[TBL] [Abstract][Full Text] [Related]
4. Semaphorin 7A plays a critical role in TGF-beta1-induced pulmonary fibrosis.
Kang HR; Lee CG; Homer RJ; Elias JA
J Exp Med; 2007 May; 204(5):1083-93. PubMed ID: 17485510
[TBL] [Abstract][Full Text] [Related]
5. Effects of thalidomide on Th17, Treg cells and TGF-β1/Smad3 pathway in a mouse model of systemic sclerosis.
Lu Y; Zhao C; Lei L; Tao Z; Zheng L; Wen J; Li X
Int J Rheum Dis; 2020 Mar; 23(3):406-419. PubMed ID: 31840939
[TBL] [Abstract][Full Text] [Related]
6. Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis.
Mazzotta C; Romano E; Bruni C; Manetti M; Lepri G; Bellando-Randone S; Blagojevic J; Ibba-Manneschi L; Matucci-Cerinic M; Guiducci S
Arthritis Res Ther; 2015 Aug; 17(1):221. PubMed ID: 26292963
[TBL] [Abstract][Full Text] [Related]
7. Induction of Inflammation and Fibrosis by Semaphorin 4A in Systemic Sclerosis.
Carvalheiro T; Affandi AJ; Malvar-Fernández B; Dullemond I; Cossu M; Ottria A; Mertens JS; Giovannone B; Bonte-Mineur F; Kok MR; Marut W; Reedquist KA; Radstake TR; García S
Arthritis Rheumatol; 2019 Oct; 71(10):1711-1722. PubMed ID: 31012544
[TBL] [Abstract][Full Text] [Related]
8. Brief report: lysyl oxidase is a potential biomarker of fibrosis in systemic sclerosis.
Rimar D; Rosner I; Nov Y; Slobodin G; Rozenbaum M; Halasz K; Haj T; Jiries N; Kaly L; Boulman N; Daood R; Vadasz Z
Arthritis Rheumatol; 2014 Mar; 66(3):726-30. PubMed ID: 24574233
[TBL] [Abstract][Full Text] [Related]
9. Semaphorin 3A: an immunoregulator in systemic sclerosis.
Rimar D; Nov Y; Rosner I; Slobodin G; Rozenbaum M; Halasz K; Haj T; Jiries N; Kaly L; Boulman N; Vadasz Z
Rheumatol Int; 2015 Oct; 35(10):1625-30. PubMed ID: 25895648
[TBL] [Abstract][Full Text] [Related]
10. Endothelial semaphorin 7A promotes seawater aspiration-induced acute lung injury through plexin C1 and β1 integrin.
Zhang M; Yan X; Liu W; Sun R; Xie Y; Jin F
Mol Med Rep; 2017 Oct; 16(4):4215-4221. PubMed ID: 28765893
[TBL] [Abstract][Full Text] [Related]
11. Semaphorin 7a+ regulatory T cells are associated with progressive idiopathic pulmonary fibrosis and are implicated in transforming growth factor-β1-induced pulmonary fibrosis.
Reilkoff RA; Peng H; Murray LA; Peng X; Russell T; Montgomery R; Feghali-Bostwick C; Shaw A; Homer RJ; Gulati M; Mathur A; Elias JA; Herzog EL
Am J Respir Crit Care Med; 2013 Jan; 187(2):180-8. PubMed ID: 23220917
[TBL] [Abstract][Full Text] [Related]
12. Semaphorin 7a promotes spreading and dendricity in human melanocytes through beta1-integrins.
Scott GA; McClelland LA; Fricke AF
J Invest Dermatol; 2008 Jan; 128(1):151-61. PubMed ID: 17671519
[TBL] [Abstract][Full Text] [Related]
13. Semaphorin 7A promotes endothelial permeability and inflammation via plexin C1 and integrin β1 in Kawasaki disease.
Huang J; Zhao C; Zhang S
BMC Pediatr; 2024 Apr; 24(1):285. PubMed ID: 38678170
[TBL] [Abstract][Full Text] [Related]
14. Correlation of Th17 cells and CD4⁺CD25⁺ regulatory T cells with clinical parameters in patients with systemic sclerosis.
Jiang N; Li M; Zeng X
Chin Med J (Engl); 2014; 127(20):3557-61. PubMed ID: 25316229
[TBL] [Abstract][Full Text] [Related]
15. Gene expression of semaphorin-3A, semaphorin-7A, neuropilin-1, plexin-C1, and β1 integrin in treated-multiple sclerosis patients.
Shapoori S; Mosayebi G; Ebrahimi Monfared M; Ghazavi A; Khansarinejad B; Farahani I; Ganji A
Neurol Res; 2020 Sep; 42(9):783-788. PubMed ID: 32497464
[TBL] [Abstract][Full Text] [Related]
16. [Effects of Wenyang Huazhuo Tongluo Recipe Containing Serum on Transforming Growth Factor β1/ Smad Signaling Pathway of Skin Fibroblasts in Systemic Sclerosis].
Bian H; Lv Q; Huang XZ; Hu JL; Yang L; Mao BY
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Sep; 35(9):1054-9. PubMed ID: 26591358
[TBL] [Abstract][Full Text] [Related]
17. Type 2 innate lymphoid cell counts are increased in patients with systemic sclerosis and correlate with the extent of fibrosis.
Wohlfahrt T; Usherenko S; Englbrecht M; Dees C; Weber S; Beyer C; Gelse K; Distler O; Schett G; Distler JH; Ramming A
Ann Rheum Dis; 2016 Mar; 75(3):623-6. PubMed ID: 26338035
[TBL] [Abstract][Full Text] [Related]
18. Elevated frequencies of CD4(+) IL-21(+) T, CD4(+) IL-21R(+) T and IL-21(+) Th17 cells, and increased levels of IL-21 in bleomycin-induced mice may be associated with dermal and pulmonary inflammation and fibrosis.
Lei L; He ZY; Zhao C; Sun XJ; Zhong XN
Int J Rheum Dis; 2016 Apr; 19(4):392-404. PubMed ID: 25545680
[TBL] [Abstract][Full Text] [Related]
19. Cartilage oligomeric matrix protein expression in systemic sclerosis reveals heterogeneity of dermal fibroblast responses to transforming growth factor beta.
Farina G; Lemaire R; Pancari P; Bayle J; Widom RL; Lafyatis R
Ann Rheum Dis; 2009 Mar; 68(3):435-41. PubMed ID: 18408251
[TBL] [Abstract][Full Text] [Related]
20. Iguratimod inhibits skin fibrosis by regulating TGF-β1/Smad signalling pathway in systemic sclerosis.
Xie X; Gan H; Tian J; Li F; Chen J; Wang J; Liao J; Li S
Eur J Clin Invest; 2022 Aug; 52(8):e13791. PubMed ID: 35441708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]